Tim Remus, PhD

Tim Remus, PhD

Tim Remus, PhD Senior Director

As director of the Cancer Service Line Strategy team, Tim leads the development and delivery of Sg2’s cancer intelligence and is the expert advisor for all oncology-related consulting projects.


"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube